Unitree Technology will list on the STAR Market on August 19 at a 219x P/E ratio, corresponding to a market cap of approximately ¥61 billion—this figure itself represents the A-share market's first public pricing of the humanoid robot sector. What's even more notable is that it took only 104 days from IPO acceptance to registration approval—the fastest record since the STAR Market's "pre-review" mechanism took effect, second only to ChangXin Memory Technologies.
What this is
Unitree is the world's #1 humanoid robot by shipment volume. On the financials, the growth story is strong: revenue grew from ¥159 million in 2023 to ¥1.699 billion in 2025, a three-year CAGR of 226.78%; 2025 non-GAAP net profit reached ¥591 million, shifting the company from losses to scaled profitability. However, Q1 2026 non-GAAP net profit came in at ¥40.25 million, down 52.55% year-over-year, driven by synchronized expansion of R&D and sales expenses.
The real significance of this listing is "first stock" rather than "first company"—it establishes the first pricing anchor for the humanoid robot sector in public markets. Previously, sector valuations relied on primary-market funding rounds and lacked referenceable public trades. After Unitree's listing, the 219x P/E will become the valuation benchmark for the entire sector.
Industry view
The fund community is clearly split into two camps. Ping An Fund's Zhang Yinxian represents the "industry pricing school": the significance of Unitree's listing lies in erecting a public-market mirror for the industrial chain—the market cap is not the endpoint but the starting point of sector valuation. ChinaAMC's Hua Long takes a middle view: there will be a scarcity premium in the early listing period, but valuations will eventually return to earnings delivery, with focus on industrial-scenario order landing and gross margin changes.
The opposing voice is equally clear. Yongying Fund's Zhang Lu focuses on earnings quality—Q1 non-GAAP net profit halved, a reminder to investors of sustainability risks under high valuations. HSBC Jinxin's Wei Yu is more direct: if embodied intelligence's breakout is delayed by five years, the 219x P/E will face downward pressure. Guotai Fund's Wu Zhonghao points out that Unitree's current lead is not necessarily the endgame—Tesla Optimus, Figure AI, AgiBot, and Fourier are all accelerating their catch-up.
Impact on regular people
For enterprises (manufacturing/industrial): Unitree's H1 and Go series have entered batch delivery at factories, exhibition halls, and research institutions. The pace of humanoid robot deployment in industrial scenarios is faster than most people expect—manufacturing companies need to start factoring this variable into production line planning.
For individual careers: Humanoid robots currently replace "repetitive physical labor + simple decision-making" positions—still far from most white-collar work—but the replacement pace for factory blue-collar workers deserves early attention.
For the consumer market: The 219x P/E is institutional pricing. A-share retail enthusiasm for IPO subscription is extremely high (social platforms show posts like "begging for one allotment to make ¥200K lying down"), with short-term speculative sentiment clearly outweighing long-term industry judgment. IPO participants need to distinguish between investing and speculating.